Insulet Corp. Reaches New 12-Month High at $36.23 (PODD)
Insulet Corp. (NASDAQ:PODD)’s share price reached a new 52-week high during trading on Wednesday, American Banking News reports. The stock traded as high as $36.23 and last traded at $35.63, with a volume of 136,577 shares traded. The stock had previously closed at $35.84.
A number of analysts have recently weighed in on PODD shares. Analysts at Jefferies Group raised their price target on shares of Insulet Corp. (NASDAQ:PODD) from $29.00 to $38.00 in a research note to investors on Friday, August 9th. Separately, analysts at JMP Securities raised their price target on shares of Insulet Corp. (NASDAQ:PODD) from $27.00 to $33.00 in a research note to investors on Thursday, August 8th. They now have a “market outperform” rating on the stock. Finally, analysts at Canaccord Genuity raised their price target on shares of Insulet Corp. (NASDAQ:PODD) from $37.00 to $40.00 in a research note to investors on Thursday, August 8th. They now have a “buy” rating on the stock.
One analyst has rated the stock with a sell rating, seven have given a hold rating and six have assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $30.77.
In other Insulet Corp. news, CEO Duane Desisto sold 20,000 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $33.38, for a total transaction of $667,600.00. Following the completion of the sale, the chief executive officer now directly owns 182,433 shares of the company’s stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Insulet Corp. has a 52-week low of $18.50 and a 52-week high of $35.90. The stock’s 50-day moving average is $33.04 and its 200-day moving average is $29.14. The company’s market cap is $1.956 billion.
Insulet Corp. (NASDAQ:PODD) last released its earnings data on Wednesday, August 7th. The company reported ($0.20) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.19) by $0.01. The company had revenue of $60.09 million for the quarter, compared to the consensus estimate of $60.47 million. During the same quarter in the prior year, the company posted ($0.30) earnings per share. The company’s quarterly revenue was up 17.7% on a year-over-year basis. Analysts expect that Insulet Corp. will post $-0.63 EPS for the current fiscal year.
Insulet Corporation is primarily engaged in the development, manufacturing and sale of its OmniPod Insulin Management System (NASDAQ:PODD).
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.